R Jones, R Plummer, V Moreno,
L Carter, D Roda… - Clinical Cancer …, 2023 - AACR
Abstract Purpose: This was a Phase I/II trial of the novel checkpoint kinase 1 (Chk1) inhibitor
SRA737 given in combination with gemcitabine. Its objectives were to establish the safety …